Completed PHASE4 INTERVENTIONAL 2-arm NCT02009215

School-Based Treatment With ACT to Reduce Transmission (START-IPT)

'SCHOOL-BASED TREATMENT WITH ACT TO REDUCE TRANSMISSION' (START-IPT): Evaluation of the Community Impact of Intermittent Preventive Treatment for Malaria in Ugandan Children: a Cluster Randomised Trial

Sponsor: Infectious Diseases Research Collaboration, Uganda

Conditions Malaria

Interventions Dihydroartemisinin-piperaquine (DP)

Updated 5 times since 2017 Last updated: Sep 23, 2015 Started: Feb 28, 2014 Primary completion: Apr 30, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Malaria, this trial is completed. The trial is conducted by Infectious Diseases Research Collaboration, Uganda and has accumulated 5 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Infectious Diseases Research Collaboration, Uganda
London School of Hygiene and Tropical Medicine
University of California, San Francisco
University of Durham

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kampala, Uganda